Connective tissue growth factor enhances osteoblastogenesis in vitro.

Connective tissue growth factor enhances osteoblastogenesis in vitro. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Connective tissue growth factor enhances osteoblastogenesis in vitro. Abstract Text:

Connective tissue growth factor enhances osteoblastogenesis in vitro. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Connective tissue growth factor enhances osteoblastogenesis in vitro. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of biological chemistry

VOLUME: 283

Page Numbers: 22690-9

Journal Abbreviation: J. Biol. Chem.

ISSN: 0021-9258

DAY: 25

MONTH: 06

YEAR: 2008

Connective tissue growth factor enhances osteoblastogenesis in vitro. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 2985121

Connective tissue growth factor enhances osteoblastogenesis in vitro. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Connective tissue growth factor enhances osteoblastogenesis in vitro. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Connective tissue growth factor enhances osteoblastogenesis in vitro.

AFFILIATION: Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105-1299 and The University of Connecticut School of Medicine, Farmington, Connecticut 06030-6220.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Biol Chem

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Connective tissue growth factor enhances osteoblastogenesis in vitro Related Publications

• Activation of the ERK pathway in osteoblastic cells, role of gremlin and BMP-2.
• Bone morphogenetic protein-2 suppresses collagenase-3 promoter activity in osteoblasts through a runt domain factor 2 binding site.
• Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts.
• CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia.
• CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation.
• Conditional deletion of gremlin causes a transient increase in bone formation and bone mass.
• Connective tissue growth factor enhances osteoblastogenesis in vitro.
• Effect of growth factors on bone cell replication and differentiation.
• Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression.
• Expression and regulation of CCN genes in murine osteoblasts.
• Gene delivery by retroviruses.
• Growth hormone, insulin-like growth factors, and the skeleton.
• Local bone growth factors.
• Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia.
• Nephroblastoma overexpressed (nov) is a novel bone morphogenetic protein antagonist.
• Notch inhibits osteoblast differentiation and causes osteopenia.
• Notch signaling in osteoblasts.
• Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures.
• Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.
• Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts.
• Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature.
• Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.